Skip to main content

rugby mucus relief d

Dosage form: tablet, extended release
Ingredients: GUAIFENESIN 600mg, PSEUDOEPHEDRINE HYDROCHLORIDE 60mg
Labeler: Rugby Laboratories
NDC code: 0536-1205

Medically reviewed by Drugs.com. Last updated on Feb 5, 2024.

Rugby Laboratories Mucus Relief D Drug Facts

Active ingredients (in each extended-release tablet)

Guaifenesin 600 mg

Pseudoephedrine HCl 60 mg

Purpose

Expectorant

Nasal Decongestant

Uses
helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
temporarily relieves nasal congestion due to:
common cold
hay fever
upper respiratory allergies
temporarily restores freer breathing through the nose
promotes nasal and/or sinus drainage
temporarily relieves sinus congestion and pressure

Warnings

Do not use if you are

now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use if you have
heart disease
high blood pressure
thyroid disease
diabetes
trouble urinating due to an enlarged prostate gland
persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
cough accompanied by too much phlegm (mucus)

When using this product
do not use more than directed

Stop use and ask a doctor if
you get nervous, dizzy, or sleepless
symptoms do not get better within 7 days, come back or occur with a fever, rash, or persistent headache. These could be signs of a serious illness.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Directions
do not crush, chew, or break tablet
take with a full glass of water
this product can be administered without regard for timing of meals
adults and children 12 years and older: 2 tablets every 12 hours; not more than 4 tablets in 24 hours
children under 12 years of age: do not use

Other information
store between 20-25°C (68-77°F)
do not use if blister unit is broken or torn

Inactive ingredients

colloidal silicon dioxide, copovidone, FD&C yellow #6 aluminum lake, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, povidone, sodium starch glycolate, stearic acid

Questions or comments?

1-800-645-2158

Package/Label Principal Display Panel

COMPARE TO active ingredients in MUCINEX® D

Mucus Relief D

Guaifenesin and Pseudoephedrine Hydrochloride

Extended-Release Tablets, 600 mg/60 mg

Expectorant/Nasal Decongestant

12 Hour

Clears Nasal/Sinus Congestion

Thins and Loosens Mucus

Actual Size

36 EXTENDED-RELEASE TABLETS

RUGBY MUCUS RELIEF D 
guaifenesin, pseudoephedrine hydrochloride tablet, extended release
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0536-1205
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GUAIFENESIN (GUAIFENESIN) GUAIFENESIN600 mg
PSEUDOEPHEDRINE HYDROCHLORIDE (PSEUDOEPHEDRINE) PSEUDOEPHEDRINE HYDROCHLORIDE60 mg
Inactive Ingredients
Ingredient NameStrength
SILICON DIOXIDE 
COPOVIDONE K25-31 
FD&C YELLOW NO. 6 
HYPROMELLOSES 
MAGNESIUM STEARATE 
MALTODEXTRIN 
CELLULOSE, MICROCRYSTALLINE 
POVIDONE 
STEARIC ACID 
Product Characteristics
ColorORANGE (peach) Scoreno score
ShapeOVAL (biconvex) Size18mm
FlavorImprint Code600;Watson
Contains    
Packaging
#Item CodePackage Description
1NDC:0536-1205-3636 BLISTER PACK in 1 CARTON
11 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
2NDC:0536-1205-2118 BLISTER PACK in 1 CARTON
21 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA09107101/14/2019
Labeler - Rugby Laboratories (079246066)

 
Rugby Laboratories

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.